相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Design, Synthesis, and Pharmacological Evaluation of Benzimidazolo-thiazoles as Potent CXCR3 Antagonists with Therapeutic Potential in Autoimmune Diseases: Discovery of ACT-672125
Eva Caroff et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Discovery and In Vivo Evaluation of ACT-660602: A Potent and Selective Antagonist of the Chemokine Receptor CXCR3 for Autoimmune Diseases
Emmanuel A. Meyer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
CXCR7 Antagonism Reduces Acute Lung Injury Pathogenesis
Laetitia Pouzol et al.
FRONTIERS IN PHARMACOLOGY (2021)
hERG toxicity assessment: Useful guidelines for drug design
Amanda Garrido et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Single-cell sequencing reveals clonal expansions of pro-inflammatory synovial CD8 T cells expressing tissue-homing receptors in psoriatic arthritis
Frank Penkava et al.
NATURE COMMUNICATIONS (2020)
Development of an efficient and sustainable synthesis of 2-(3-methyl-1H-1,2,4-triazol-1-yl) acetic acid under continuous-flow conditions
Simone Tortoioti et al.
GREEN CHEMISTRY (2020)
Taming Ambident Triazole Anions: Regioselective Ion Pairing Catalyzes Direct N-Alkylation with Atypical Regioselectivity
Harvey J. A. Dale et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2019)
Decreasing the CYP2D6 contribution to metabolism of a CK1 epsilon inhibitor
Roy J. Vaz et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
The Role of CXCR3 and Its Chemokine Ligands in Skin Disease and Cancer
Paula T. Kuo et al.
FRONTIERS IN MEDICINE (2018)
Designing small molecule CXCR3 antagonists
James E. Pease
EXPERT OPINION ON DRUG DISCOVERY (2017)
Eldelumab [anti-interferon-γ-inducible protein-10 antibody] Induction Therapy for Active Crohn's Disease: a Randomised, Double-blind, Placebo-controlled Phase IIa Study
William J. Sandborn et al.
JOURNAL OF CROHNS & COLITIS (2017)
CXCL10/IP-10 Neutralization Can Ameliorate Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome in Rats
Shan Lang et al.
PLOS ONE (2017)
Eldelumab [Anti-IP-10] Induction Therapy for Ulcerative Colitis: A Randomised, Placebo-Controlled, Phase 2b Study
William J. Sandborn et al.
JOURNAL OF CROHNS & COLITIS (2016)
Small Molecule CXCR3 Antagonists
Stephen P. Andrews et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Utilizing Structures of CYP2D6 and BACE1 Complexes To Reduce Risk of Drug-Drug Interactions with a Novel Series of Centrally Efficacious BACE1 Inhibitors
Michael A. Brodney et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Anti-IP-10 antibody (BMS-936557) for ulcerative colitis: a phase II randomised study
Lloyd Mayer et al.
GUT (2014)
The Revised Human Liver Cytochrome P450 Pie: Absolute Protein Quantification of CYP4F and CYP3A Enzymes Using Targeted Quantitative Proteomics
Scott Michaels et al.
DRUG METABOLISM AND DISPOSITION (2014)
Pharmacometric Analyses to Support Early Development Decisions for LY2878735: A Novel Serotonin Norepinephrine Reuptake Inhibitor
E. Raddad et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2013)
A phase II, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of MDX-1100, a fully human anti-CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis
Michael Yellin et al.
ARTHRITIS AND RHEUMATISM (2012)
CXCR3 ligands: redundant, collaborative and antagonistic functions
Joanna R. Groom et al.
IMMUNOLOGY AND CELL BIOLOGY (2011)
Desipramine, substrate for CYP2D6 activity: population pharmacokinetic model and design elements of drug-drug interaction trials
Ivelina Gueorguieva et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance Part I
Shu-Feng Zhou
CLINICAL PHARMACOKINETICS (2009)
Coexpression and interaction of CXCL10 and CD26 in mesenchymal cells by synergising inflammatory cytokines: CXCL8 and CXCL10 are discriminative markers for autoimmune arthropathies
Paul Proost et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Antibody-mediated blockade of the CXCR3 chemokine receptor results in diminished recruitment of T helper 1 cells into sites of inflammation
JH Xie et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)
An investigation into the alkylation of 1,2,4-triazole
PG Bulger et al.
TETRAHEDRON LETTERS (2000)